Comstock Inc.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
LODE$1.67-13.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
| Additional · Non- | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Paid in · Accumulated · Controlling | ||||||
| Shares | Amount | Capital | Deficit | Interest | Total | |
| BALANCE - January 1, 2025 | 23,507,577 | $156,590 | $395,263,560 | $(335,651,065) | $— | $59,769,085 |
| Common stock issuance costs | — | — | (145,000) | — | — | (145,000) |
| Issuance of common stock - debt issuance costs | 110,059 | 733 | 531,182 | — | — | 531,915 |
| Issuance of common stock - debt and accrued interest | 1,490,624 | 1,798 | 3,999,445 | — | — | 4,001,243 |
| Issuance of common stock - interest payments | 35,366 | 117 | 142,305 | — | — | 142,422 |
| Issuance of common stock - AST amendment | 985,000 | 656 | 2,481,544 | — | — | 2,482,200 |
| Issuance of common stock - LINICO acquisition-related commitment | 775,000 | 516 | 1,859,484 | — | — | 1,860,000 |
| Adjustment for fractional shares - reverse split | 246 | — | — | — | — | — |
| Net loss | — | — | — | (9,093,931) | — | (9,093,931) |
| BALANCE - March 31, 2025 | 26,903,872 | 160,410 | 404,132,520 | (344,744,996) | — | 59,547,934 |
| Issuance of common stock | 625,000 | 416 | 1,499,584 | — | — | 1,500,000 |
| Issuance of common stock - debt and accrued interest | 2,629,601 | 1,751 | 6,736,748 | — | — | 6,738,499 |
| Issuance of common stock - interest payments | 57,693 | 38 | 142,066 | — | — | 142,104 |
| Issuance of common stock - Haywood amendment | 200,000 | 133 | 699,867 | — | — | 700,000 |
| Issuance of common stock - Flux Photon amendment | 2,000,000 | 1,333 | 5,778,667 | — | — | 5,780,000 |
| Non-controlling interest of shares in subsidiary for CP Series A investment | — | — | 19,336,362 | — | 663,638 | 20,000,000 |
| Non-controlling interest of shares in subsidiary for Founder's Group shares | — | — | 2,643,618 | — | 2,636,382 | 5,280,000 |
| Net loss | — | — | — | (7,826,943) | — | (7,826,943) |
| BALANCE - June 30, 2025 | 32,416,166 | 164,081 | 440,969,432 | (352,571,939) | 3,300,020 | 91,861,594 |
| Issuance of common stock and warrants | 15,333,334 | 10,212 | 34,489,790 | — | — | 34,500,002 |
| Common stock issuance costs | — | — | (2,889,663) | — | — | (2,889,663) |
| Issuance of common stock - Northern Comstock LLC for mineral rights | 132,573 | 88 | 482,412 | — | — | 482,500 |
| Issuance of common stock - debt and accrued interest | 447,724 | 298 | 1,110,057 | — | — | 1,110,355 |
| Issuance of common stock - interest payments | 34,450 | 23 | 116,974 | — | — | 116,997 |
| Issuance of common stock - debt payment | 2,900,000 | 1,932 | 9,191,068 | — | — | 9,193,000 |
| Warrant modification - debt amendments | — | — | 203,800 | — | — | 203,800 |
| Net loss | — | — | — | (12,888,336) | — | (12,888,336) |
| BALANCE - September 30, 2025 | 51,264,247 | $176,634 | $483,673,870 | $(365,460,275) | $3,300,020 | $121,690,249 |
| BALANCE - January 1, 2026 | 51,853,490 | $177,026 | $486,130,452 | $(378,727,508) | $3,321,020 | $110,900,990 |
| Issuance of common stock and warrants | 21,781,929 | 14,507 | 60,964,674 | — | — | 60,979,181 |
| Common stock issuance costs | — | — | (4,606,575) | — | — | (4,606,575) |
| Issuance of common stock - director fees | 463,721 | 309 | 1,863,850 | — | — | 1,864,159 |
| Net loss | — | — | — | (9,383,417) | — | (9,383,417) |
| BALANCE - March 31, 2026 | 74,099,140 | 191,842 | 544,352,401 | (388,110,925) | 3,321,020 | 159,754,338 |
| Issuance of common stock - Flux Photon agreement | 1,750,000 | 1,166 | 6,053,834 | — | — | 6,055,000 |
| Issuance of common stock - director fees | 63,944 | 42 | 210,414 | — | — | 210,456 |
| Stock-based compensation - employees | — | — | 116,566 | — | — | 116,566 |
| Issuance of common stock - cashless warrant exercise | 38,369 | 25 | (25) | — | — | — |
| Net loss | — | — | — | (25,468,401) | — | (25,468,401) |
| BALANCE - June 30, 2026 | 75,951,453 | 193,075 | 550,733,190 | (413,579,326) | 3,321,020 | 140,667,959 |
| Issuance of common stock - director fees | 41,594 | 28 | 169,795 | — | — | 169,823 |
| Stock-based compensation - employees | — | — | 667,942 | — | — | 667,942 |
| Net loss | — | — | — | (753,455) | — | (753,455) |
| BALANCE - September 30, 2026 | 75,993,047 | $193,103 | $551,570,927 | $(414,332,781) | $3,321,020 | $140,752,269 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.